ID   ANPRB_HUMAN             Reviewed;        1047 AA.
AC   P20594; B0ZBF2; B0ZBF3; O60871; Q4VAK7; Q5TCV2; Q8TA93; Q9UQ50;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   05-OCT-2010, entry version 126.
DE   RecName: Full=Atrial natriuretic peptide receptor 2;
DE            EC=4.6.1.2;
DE   AltName: Full=Atrial natriuretic peptide receptor type B;
DE            Short=ANP-B;
DE            Short=ANPR-B;
DE            Short=NPR-B;
DE   AltName: Full=Guanylate cyclase B;
DE            Short=GC-B;
DE   Flags: Precursor;
GN   Name=NPR2; Synonyms=ANPRB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ISOFORM LONG).
RC   TISSUE=Brain;
RX   MEDLINE=89365195; PubMed=2570358; DOI=10.1038/341068a0;
RA   Chang M.S., Lowe D.G., Lewis M., Hellmiss R., Chen E., Goeddel D.V.;
RT   "Differential activation by atrial and brain natriuretic peptides of
RT   two different receptor guanylate cyclases.";
RL   Nature 341:68-72(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   MEDLINE=99182382; PubMed=10082481;
RA   Rehemudula D., Nakayama T., Soma M., Takahashi Y., Uwabo J., Sato M.,
RA   Izumi Y., Kanmatsuse K., Ozawa Y.;
RT   "Structure of the type B human natriuretic peptide receptor gene and
RT   association of a novel microsatellite polymorphism with essential
RT   hypertension.";
RL   Circ. Res. 84:605-610(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RC   TISSUE=Kidney;
RX   MEDLINE=99171605; PubMed=10073597;
RA   Hirsch J.R., Meyer M., Maegert H.-J., Forssmann W.-G., Mollerup S.,
RA   Herter P., Weber G., Cermak R., Ankorina-Stark I., Schlatter E.,
RA   Kruhoffer M.;
RT   "cGMP-dependent and -independent inhibition of a K+ conductance by
RT   natriuretic peptides: molecular and functional studies in human
RT   proximal tubule cells.";
RL   J. Am. Soc. Nephrol. 10:472-480(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   LIGAND-BINDING.
RX   PubMed=1660465;
RA   Bennett B.D., Bennett G.L., Vitangcol R.V., Jewett J.R., Burnier J.,
RA   Henzel W., Lowe D.G.;
RT   "Extracellular domain-IgG fusion proteins for three human natriuretic
RT   peptide receptors. Hormone pharmacology and application to solid phase
RT   screening of synthetic peptide antisera.";
RL   J. Biol. Chem. 266:23060-23067(1991).
RN   [9]
RP   FUNCTION.
RX   PubMed=1672777; DOI=10.1126/science.1672777;
RA   Koller K.J., Lowe D.G., Bennett G.L., Minamino N., Kangawa K.,
RA   Matsuo H., Goeddel D.V.;
RT   "Selective activation of the B natriuretic peptide receptor by C-type
RT   natriuretic peptide (CNP).";
RL   Science 252:120-123(1991).
RN   [10]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [11]
RP   FUNCTION, VARIANTS AMDM THR-32; GLY-115; GLU-176; MET-297; CYS-338;
RP   THR-409; GLU-413; CYS-708; TRP-776; CYS-957 AND ALA-959, AND
RP   CHARACTERIZATION OF VARIANTS AMDM GLY-115; MET-297 AND GLU-413.
RX   PubMed=15146390; DOI=10.1086/422013;
RA   Bartels C.F., Buekuelmez H., Padayatti P., Rhee D.K.,
RA   van Ravenswaaij-Arts C., Pauli R.M., Mundlos S., Chitayat D.,
RA   Shih L.-Y., Al-Gazali L.I., Kant S., Cole T., Morton J.,
RA   Cormier-Daire V., Faivre L., Lees M., Kirk J., Mortier G.R., Leroy J.,
RA   Zabel B., Kim C.A., Crow Y., Braverman N.E., van den Akker F.,
RA   Warman M.L.;
RT   "Mutations in the transmembrane natriuretic peptide receptor NPR-B
RT   impair skeletal growth and cause acromesomelic dysplasia, type
RT   Maroteaux.";
RL   Am. J. Hum. Genet. 75:27-34(2004).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-232 AND ILE-882.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for the C-type natriuretic peptide NPPC/CNP
CC       hormone. Has guanylate cyclase activity upon binding of its
CC       ligand. May play a role in the regulation of skeletal growth.
CC   -!- CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P20594-1; Sequence=Displayed;
CC       Name=Short; Synonyms=NPR-BI;
CC         IsoId=P20594-2; Sequence=VSP_001810;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay;
CC   -!- PTM: Phosphorylation of the protein kinase-like domain is required
CC       for full activation by CNP (By similarity).
CC   -!- DISEASE: Defects in NPR2 are the cause of acromesomelic dysplasia
CC       Maroteaux type (AMDM) [MIM:602875]. Acromesomelic
CC       chondrodysplasias are rare hereditary skeletal disorders
CC       characterized by short stature, very short limbs, and hand/foot
CC       malformations. The severity of limb abnormalities increases from
CC       proximal to distal with profoundly affected hands and feet showing
CC       brachydactyly and/or rudimentary fingers (knob-like fingers). AMDM
CC       is an autosomal recessive form characterized by axial skeletal
CC       involvement with wedging of vertebral bodies. In AMDM all skeletal
CC       elements are present but show abnormal rates of linear growth.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl
CC       cyclase family.
CC   -!- SIMILARITY: Contains 1 guanylate cyclase domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB005647; BAA81737.1; -; Genomic_DNA.
DR   EMBL; AJ005282; CAA06466.1; -; mRNA.
DR   EMBL; AL133410; CAI10987.1; -; Genomic_DNA.
DR   EMBL; EU326311; ACA05920.1; -; Genomic_DNA.
DR   EMBL; EU326311; ACA05921.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58338.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58337.1; -; Genomic_DNA.
DR   EMBL; BC023017; AAH23017.1; -; mRNA.
DR   IPI; IPI00024685; -.
DR   IPI; IPI00219001; -.
DR   PIR; S05514; OYHUBR.
DR   RefSeq; NP_003986.2; -.
DR   UniGene; Hs.78518; -.
DR   ProteinModelPortal; P20594; -.
DR   SMR; P20594; 24-441, 491-789, 855-1040.
DR   STRING; P20594; -.
DR   PhosphoSite; P20594; -.
DR   PRIDE; P20594; -.
DR   Ensembl; ENST00000342694; ENSP00000341083; ENSG00000159899.
DR   GeneID; 4882; -.
DR   KEGG; hsa:4882; -.
DR   UCSC; uc003zyd.1; human.
DR   UCSC; uc010mlb.1; human.
DR   CTD; 4882; -.
DR   GeneCards; GC09P035792; -.
DR   HGNC; HGNC:7944; NPR2.
DR   HPA; HPA011977; -.
DR   MIM; 108961; gene.
DR   MIM; 602875; phenotype.
DR   Orphanet; 40; Acromesomelic dysplasia, Maroteaux type.
DR   PharmGKB; PA257; -.
DR   eggNOG; prNOG13787; -.
DR   HOGENOM; HBG714686; -.
DR   HOVERGEN; HBG051862; -.
DR   InParanoid; P20594; -.
DR   OMA; QVYTREP; -.
DR   OrthoDB; EOG9SBHH5; -.
DR   PhylomeDB; P20594; -.
DR   BRENDA; 4.6.1.2; 247.
DR   DrugBank; DB01613; Erythrityl Tetranitrate.
DR   DrugBank; DB04899; Nesiritide.
DR   NextBio; 18792; -.
DR   ArrayExpress; P20594; -.
DR   Bgee; P20594; -.
DR   CleanEx; HS_NPR2; -.
DR   Genevestigator; P20594; -.
DR   GermOnline; ENSG00000159899; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:ProtInc.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IDA:UniProtKB.
DR   GO; GO:0016941; F:natriuretic peptide receptor activity; IDA:UniProtKB.
DR   GO; GO:0008528; F:peptide receptor activity, G-protein coupled; IEA:InterPro.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0001503; P:ossification; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007168; P:receptor guanylyl cyclase signaling pathway; IDA:UniProtKB.
DR   GO; GO:0008217; P:regulation of blood pressure; TAS:ProtInc.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR001170; Ntpep_rcpt_N.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   Gene3D; G3DSA:3.30.70.1230; A/G_cyclase; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00211; Guanylate_cyc; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00255; NATPEPTIDER.
DR   SMART; SM00044; CYCc; 1.
DR   SUPFAM; SSF55073; A/G_cyclase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00458; ANF_RECEPTORS; 1.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; cGMP biosynthesis; Complete proteome;
KW   Disease mutation; Disulfide bond; Dwarfism; Glycoprotein; GTP-binding;
KW   Lyase; Membrane; Nucleotide-binding; Osteogenesis; Phosphoprotein;
KW   Polymorphism; Receptor; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     22       Potential.
FT   CHAIN        23   1047       Atrial natriuretic peptide receptor 2.
FT                                /FTId=PRO_0000012364.
FT   TOPO_DOM     23    458       Extracellular (Potential).
FT   TRANSMEM    459    478       Helical; (Potential).
FT   TOPO_DOM    479   1047       Cytoplasmic (Potential).
FT   DOMAIN      513    786       Protein kinase.
FT   DOMAIN      861    991       Guanylate cyclase.
FT   MOD_RES     513    513       Phosphoserine (By similarity).
FT   MOD_RES     516    516       Phosphothreonine (By similarity).
FT   MOD_RES     518    518       Phosphoserine (By similarity).
FT   MOD_RES     523    523       Phosphoserine (By similarity).
FT   MOD_RES     526    526       Phosphoserine (By similarity).
FT   CARBOHYD     24     24       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     35     35       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    161    161       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    195    195       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    244    244       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    277    277       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    349    349       N-linked (GlcNAc...) (Potential).
FT   DISULFID     75    101       By similarity.
FT   DISULFID    439    439       Interchain (Probable).
FT   DISULFID    448    448       Interchain (Probable).
FT   VAR_SEQ     964   1047       PVCAGVVGLKMPRYCLFGDTVNTASRMESNGQALKIHVSST
FT                                TKDALDELGCFQLELRGDVEMKGKGKMRTYWLLGERKGPPG
FT                                LL -> KADSHSSPSLHLSQTLPTCFFSKGQSVLGLLA
FT                                (in isoform Short).
FT                                /FTId=VSP_001810.
FT   VARIANT      32     32       P -> T (in AMDM; dbSNP:rs28931581).
FT                                /FTId=VAR_022583.
FT   VARIANT     115    115       W -> G (in AMDM; markedly deficient
FT                                activity; dbSNP:rs28931582).
FT                                /FTId=VAR_022584.
FT   VARIANT     176    176       D -> E (in AMDM; dbSNP:rs28929479).
FT                                /FTId=VAR_022585.
FT   VARIANT     232    232       M -> I (in dbSNP:rs55747238).
FT                                /FTId=VAR_042219.
FT   VARIANT     297    297       T -> M (in AMDM; markedly deficient
FT                                activity).
FT                                /FTId=VAR_022586.
FT   VARIANT     338    338       Y -> C (in AMDM).
FT                                /FTId=VAR_022587.
FT   VARIANT     409    409       A -> T (in AMDM).
FT                                /FTId=VAR_022588.
FT   VARIANT     413    413       G -> E (in AMDM; markedly deficient
FT                                activity).
FT                                /FTId=VAR_022589.
FT   VARIANT     708    708       Y -> C (in AMDM).
FT                                /FTId=VAR_022590.
FT   VARIANT     771    771       Q -> E (in dbSNP:rs5816).
FT                                /FTId=VAR_011968.
FT   VARIANT     776    776       R -> W (in AMDM).
FT                                /FTId=VAR_022591.
FT   VARIANT     882    882       V -> I (in dbSNP:rs55700371).
FT                                /FTId=VAR_042220.
FT   VARIANT     957    957       R -> C (in AMDM).
FT                                /FTId=VAR_022592.
FT   VARIANT     959    959       G -> A (in AMDM).
FT                                /FTId=VAR_022593.
FT   CONFLICT    755    755       T -> S (in Ref. 2; BAA81737).
SQ   SEQUENCE   1047 AA;  117022 MW;  817FB74D6B31F7EF CRC64;
     MALPSLLLLV AALAGGVRPP GARNLTLAVV LPEHNLSYAW AWPRVGPAVA LAVEALGRAL
     PVDLRFVSSE LEGACSEYLA PLSAVDLKLY HDPDLLLGPG CVYPAASVAR FASHWRLPLL
     TAGAVASGFS AKNDHYRTLV RTGPSAPKLG EFVVTLHGHF NWTARAALLY LDARTDDRPH
     YFTIEGVFEA LQGSNLSVQH QVYAREPGGP EQATHFIRAN GRIVYICGPL EMLHEILLQA
     QRENLTNGDY VFFYLDVFGE SLRAGPTRAT GRPWQDNRTR EQAQALREAF QTVLVITYRE
     PPNPEYQEFQ NRLLIRARED FGVELGPSLM NLIAGCFYDG ILLYAEVLNE TIQEGGTRED
     GLRIVEKMQG RRYHGVTGLV VMDKNNDRET DFVLWAMGDL DSGDFQPAAH YSGAEKQIWW
     TGRPIPWVKG APPSDNPPCA FDLDDPSCDK TPLSTLAIVA LGTGITFIMF GVSSFLIFRK
     LMLEKELASM LWRIRWEELQ FGNSERYHKG AGSRLTLSLR GSSYGSLMTA HGKYQIFANT
     GHFKGNVVAI KHVNKKRIEL TRQVLFELKH MRDVQFNHLT RFIGACIDPP NICIVTEYCP
     RGSLQDILEN DSINLDWMFR YSLINDLVKG MAFLHNSIIS SHGSLKSSNC VVDSRFVLKI
     TDYGLASFRS TAEPDDSHAL YAKKLWTAPE LLSGNPLPTT GMQKADVYSF GIILQEIALR
     SGPFYLEGLD LSPKEIVQKV RNGQRPYFRP SIDRTQLNEE LVLLMERCWA QDPAERPDFG
     QIKGFIRRFN KEGGTSILDN LLLRMEQYAN NLEKLVEERT QAYLEEKRKA EALLYQILPH
     SVAEQLKRGE TVQAEAFDSV TIYFSDIVGF TALSAESTPM QVVTLLNDLY TCFDAIIDNF
     DVYKVETIGD AYMVVSGLPG RNGQRHAPEI ARMALALLDA VSSFRIRHRP HDQLRLRIGV
     HTGPVCAGVV GLKMPRYCLF GDTVNTASRM ESNGQALKIH VSSTTKDALD ELGCFQLELR
     GDVEMKGKGK MRTYWLLGER KGPPGLL
//
